🇺🇸 DAPT intensification in United States

DAPT intensification (DAPT intensification) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

DAPT intensification in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is DAPT intensification approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for DAPT intensification in United States?

Kaiser Franz Josef Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.